FindTrial
Sign In

Outcomes of rTMS in Cancer Patients with Psychosomatic Disease

Clinical Feasibility and Short-term Outcomes of rTMS in Cancer Patients with Psychosomatic Disease: A Prospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106940
Enrollment
50
Registered
2026-03-27
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C801- Malignant (primary) neoplasm, unspecified

Interventions

Intervention1: rTMS: single arm rTMS 10Hz 120 percent RMT 3000 pulses per session for 10 sessions over 2 weeks Control Intervention1: NIL: NIL

Sponsors

MLN Medical College Lowther Road Prayagraj UP India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult cancer patients 20 to 65 years with DSM 5 SSD or PHQ 15 more than or equal to 10 stable on current cancer treatment who give consent for r TMS

Exclusion criteria

Exclusion criteria: cancer patients less than 20 or more than 65 years and those who do not give consent for r TMS

Design outcomes

Primary

MeasureTime frame
Evaluate the effect of this intervention more than or equal to 20-30 percent reduction in PHQ15 somatic symptomsTimepoint: Baseline day1,2weeks post treatment 4 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Virendra Singh

MLN Medical College Prayagraj

singhv2003@gmail.com9044815664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026